ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Shandong Boan Biotechnology Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate 4.66% of over the last 5 years
- The company is Net-Debt Free
2
Negative results in Dec 25
- INTEREST COVERAGE RATIO(Q) Lowest at 207.12
- DEBTORS TURNOVER RATIO(HY) Lowest at 1.3 times
- PRE-TAX PROFIT(Q) Lowest at HKD -14.64 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -43.68%, its profits have risen by 87.2% ; the PEG ratio of the company is 0.2
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -43.68% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Shandong Boan Biotechnology Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shandong Boan Biotechnology Co., Ltd.
-43.68%
-0.54
63.83%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.07%
EBIT Growth (5y)
4.66%
EBIT to Interest (avg)
-0.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
41.27
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.99
EV to EBIT
-90.95
EV to EBITDA
-93.14
EV to Capital Employed
1.90
EV to Sales
11.34
PEG Ratio
0.19
Dividend Yield
NA
ROCE (Latest)
-2.09%
ROE (Latest)
19.10%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(Q)
Highest at HKD 428.5 MM
RAW MATERIAL COST(Y)
Fallen by -1.79% (YoY
CASH AND EQV(HY)
Highest at HKD 1,261.9 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -11.13 %
INVENTORY TURNOVER RATIO(HY)
Highest at 1.49 times
-12What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 207.12
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.3 times
PRE-TAX PROFIT(Q)
Lowest at HKD -14.64 MM
NET PROFIT(Q)
Lowest at HKD -14.64 MM
EPS(Q)
Lowest at HKD -0.02
Here's what is working for Shandong Boan Biotechnology Co., Ltd.
Net Sales
Highest at HKD 428.5 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Cash and Eqv
Highest at HKD 1,261.9 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -11.13 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 1.49 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -1.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 52.49 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Depreciation
At HKD 52.49 MM has Grown at 22.54%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Shandong Boan Biotechnology Co., Ltd.
Pre-Tax Profit
At HKD -14.64 MM has Fallen at -217.15%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -14.64 MM has Fallen at -217.15%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (HKD MM)
Interest Coverage Ratio
Lowest at 207.12
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Pre-Tax Profit
Lowest at HKD -14.64 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Net Profit
Lowest at HKD -14.64 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
EPS
Lowest at HKD -0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
Debtors Turnover Ratio
Lowest at 1.3 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
